Genedx Holdings Corp (WGS)

$60.93 +1.93 (3.27%)
Market Cap 1.68B
Revenue (ttm) 305.45M
Net Income (ttm) -52.29M
EPS (ttm) N/A
PE Ratio 68.48
Forward PE 64.25
Profit Margin -17.12%
Debt to Equity Ratio 0.21
Volume 1,665,600
Avg Vol 1,124,196
Day's Range N/A - N/A
Shares Out 28.53M
Stochastic %K 6%
Beta 1.96
Analysts Strong Sell
Price Target $93.67

Latest News on WGS

GeneDx: Time To Buy The Dip

May 14, 2025, 5:35 AM EDT - 1 hour ago

GeneDx: Time To Buy The Dip

GeneDx Announces Completion of Fabric Genomics Acquisition

May 7, 2025, 8:30 AM EDT - 6 days ago

GeneDx Announces Completion of Fabric Genomics Acquisition

GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 1:15 PM EDT - 13 days ago

GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

Apr 30, 2025, 6:30 AM EDT - 14 days ago

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

GeneDx: Strengthening Leadership In Genomic Diagnostics

Apr 28, 2025, 11:13 AM EDT - 15 days ago

GeneDx: Strengthening Leadership In Genomic Diagnostics

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

Apr 16, 2025, 6:00 AM EDT - 4 weeks ago

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

Apr 8, 2025, 8:05 AM EDT - 5 weeks ago

GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

Apr 3, 2025, 8:00 AM EDT - 5 weeks ago

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 20, 2025, 4:05 PM EDT - 7 weeks ago

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

Mar 18, 2025, 7:05 AM EDT - 2 months ago

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

Mar 13, 2025, 8:30 AM EDT - 2 months ago

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

Mar 13, 2025, 8:30 AM EDT - 2 months ago

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich

Mar 12, 2025, 1:13 PM EDT - 2 months ago

GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

Mar 4, 2025, 8:30 AM EST - 2 months ago

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Connect

Feb 25, 2025, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Connect

Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols

Feb 24, 2025, 11:00 AM EST - 2 months ago

Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out

Feb 24, 2025, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the Investigation

Feb 23, 2025, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the Investigation

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 21, 2025, 10:00 AM EST - 2 months ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 20, 2025, 10:00 AM EST - 2 months ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect

Feb 19, 2025, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect

Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy'

Feb 19, 2025, 9:29 AM EST - 2 months ago

Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy'

GeneDx CEO on pediatric genetic testing, future of genome sequencing and share surge

Feb 18, 2025, 3:54 PM EST - 3 months ago

GeneDx CEO on pediatric genetic testing, future of genome sequencing and share surge

GeneDx Holdings Corp. (WGS) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 11:02 AM EST - 3 months ago

GeneDx Holdings Corp. (WGS) Q4 2024 Earnings Call Transcript

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Stockholders to Inquire about Securities Investigation

Feb 18, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Stockholders to Inquire about Securities Investigation

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

Feb 18, 2025, 6:00 AM EST - 3 months ago

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Investors to Learn More About the Investigation

Feb 17, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Reach Out

Feb 14, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect

Feb 13, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect

GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients

Feb 13, 2025, 8:30 AM EST - 3 months ago

GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients

GeneDx to Participate in 45th Annual TD Cowen Health Care Conference

Feb 12, 2025, 4:05 PM EST - 3 months ago

GeneDx to Participate in 45th Annual TD Cowen Health Care Conference

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Feb 12, 2025, 10:00 AM EST - 3 months ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Stockholders to Learn More About the Investigation

Feb 11, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Investors to Inquire about Securities Investigation

Feb 10, 2025, 12:00 PM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Investors to Inquire about Securities Investigation

GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment

Feb 10, 2025, 8:30 AM EST - 3 months ago

GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment